Clinical Trials Directory

Trials / Unknown

UnknownNCT02552758

The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Shanghai Mental Health Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Investigators plan to explore whether Omega-3 fatty acid have effect on the violent behavior of the schizophrenia patients. Investigators will use PET to explore the influence on serotonin function of the brain to understand the mechanism of how Omega-3 fatty acid works. This study will enroll 100 patients of schizophrenia with violent behavior.Participants will be split into two groups randomly. In one group, participants will receive one pill of placebo per day, and in the other, participants will have one pill of 900mg Omega-3 fatty acid per day. This intervention will last 3 months.At week 0, week 4, week 8 and week 12, some scales will be evaluated. Meanwhile, the density of eicosapentaenoic acid(EPA),docosahexaenoic acid (DHA),noradrenalin(NE), dopamine(DA) and serotonin(5-HT) in blood will be tested.At week 0 and week 12, 10 patients of each group will be randomly selected to have the exam of PET.

Conditions

Interventions

TypeNameDescription
BIOLOGICALomega-3 fatty acidomega-3 fatty acid
BIOLOGICALplaceboplacebo
DEVICEpositron emission tomography (PET)

Timeline

Start date
2015-05-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2015-09-17
Last updated
2015-09-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02552758. Inclusion in this directory is not an endorsement.